Menu Back toDay-2-Session-5-Compliance-Management

"PV Fast Forward" - Technology, Pace, Priority.

Day 2 : Session 5 - Compliance Management

Session Chair(s)

Mangesh  Kulkarni, MD

Mangesh Kulkarni, MD

  • Global Drug Safety - Physician and Head of Practice
  • Tata Consultancy Services, India


Seema  Jaitly, DrMed

Session 5.1: Risk Minimisation Activities & Evalution of Effectiveness

Seema Jaitly, DrMed

  • Managing Director
  • Essjay Solutions Ltd, United Kingdom
Savitha  Hanuman, MPharm

Sesson 5.2: A risk based approach to real time compliance

Savitha Hanuman, MPharm

  • VP. Accenture Life Sciences Operations
  • Accenture, India
J Vijay  Venkatraman, MD, MBA

Session 5.3 : Indian Pharmacovigilance - Where do we stand today

J Vijay Venkatraman, MD, MBA

  • Managing Director and CEO
  • Oviya MedSafe, India

Contact us